140 related articles for article (PubMed ID: 36865103)
1. Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response.
Sarkar S; Elliott EC; Henry HR; Ludovico ID; Melchior JT; Frazer-Abel A; Webb-Robertson BJ; Davidson WS; Holers VM; Rewers MJ; Metz TO; Nakayasu ES
medRxiv; 2023 Feb; ():. PubMed ID: 36865103
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response.
Sarkar S; Elliott EC; Henry HR; Ludovico ID; Melchior JT; Frazer-Abel A; Webb-Robertson BJ; Davidson WS; Holers VM; Rewers MJ; Metz TO; Nakayasu ES
Clin Proteomics; 2023 Sep; 20(1):38. PubMed ID: 37735622
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity.
Nakayasu ES; Bramer LM; Ansong C; Schepmoes AA; Fillmore TL; Gritsenko MA; Clauss TR; Gao Y; Piehowski PD; Stanfill BA; Engel DW; Orton DJ; Moore RJ; Qian WJ; Sechi S; Frohnert BI; Toppari J; Ziegler AG; Lernmark Å; Hagopian W; Akolkar B; Smith RD; Rewers MJ; Webb-Robertson BM; Metz TO;
Cell Rep Med; 2023 Jul; 4(7):101093. PubMed ID: 37390828
[TBL] [Abstract][Full Text] [Related]
5. Circulating biomarkers during progression to type 1 diabetes: A systematic review.
Brenu EW; Harris M; Hamilton-Williams EE
Front Endocrinol (Lausanne); 2023; 14():1117076. PubMed ID: 36817583
[TBL] [Abstract][Full Text] [Related]
6. Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.
Kim PY; Tan O; Diakiw SM; Carter D; Sekerye EO; Wasinger VC; Liu T; Kavallaris M; Norris MD; Haber M; Chesler L; Dolnikov A; Trahair TN; Cheung NK; Marshall GM; Cheung BB
J Proteomics; 2014 Jan; 96():1-12. PubMed ID: 24200836
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
8. Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression.
Liu CW; Bramer L; Webb-Robertson BJ; Waugh K; Rewers MJ; Zhang Q
J Proteomics; 2018 Feb; 172():100-110. PubMed ID: 28993202
[TBL] [Abstract][Full Text] [Related]
9. Expression-based Genome-wide Association Study Links OPN and IL1-RA With Newly Diagnosed Type 1 Diabetes in Children.
Jia X; Toda K; He L; Miao D; Yamada S; Yu L; Kodama K
J Clin Endocrinol Metab; 2022 Jun; 107(7):1825-1832. PubMed ID: 35460250
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry-Based Proteomics for Discovering Salivary Biomarkers in Periodontitis: A Systematic Review.
Hu H; Leung WK
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834046
[TBL] [Abstract][Full Text] [Related]
11. Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology.
Maahs DM; Siwy J; Argilés A; Cerna M; Delles C; Dominiczak AF; Gayrard N; Iphöfer A; Jänsch L; Jerums G; Medek K; Mischak H; Navis GJ; Roob JM; Rossing K; Rossing P; Rychlík I; Schiffer E; Schmieder RE; Wascher TC; Winklhofer-Roob BM; Zimmerli LU; Zürbig P; Snell-Bergeon JK
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927192
[TBL] [Abstract][Full Text] [Related]
12. Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.
Kingery SE; Wu YL; Zhou B; Hoffman RP; Yu CY
Pediatr Diabetes; 2012 Aug; 13(5):408-18. PubMed ID: 22151770
[TBL] [Abstract][Full Text] [Related]
13. Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young.
Elhassan S; Dong F; Buckner T; Johnson RK; Seifert JA; Carry PM; Vanderlinden L; Waugh K; Rewers M; Norris JM
Front Immunol; 2023; 14():1124370. PubMed ID: 37056761
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
[TBL] [Abstract][Full Text] [Related]
15. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
16. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.
Cohen Freue GV; Meredith A; Smith D; Bergman A; Sasaki M; Lam KK; Hollander Z; Opushneva N; Takhar M; Lin D; Wilson-McManus J; Balshaw R; Keown PA; Borchers CH; McManus B; Ng RT; McMaster WR;
PLoS Comput Biol; 2013 Apr; 9(4):e1002963. PubMed ID: 23592955
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
18. Serological autoantibody profiling of type 1 diabetes by protein arrays.
Miersch S; Bian X; Wallstrom G; Sibani S; Logvinenko T; Wasserfall CH; Schatz D; Atkinson M; Qiu J; LaBaer J
J Proteomics; 2013 Dec; 94():486-96. PubMed ID: 24148850
[TBL] [Abstract][Full Text] [Related]
19. Progression of Type 1 Diabetes: Circulating MicroRNA Expression Profiles Changes from Preclinical to Overt Disease.
Santos AS; Ferreira LRP; da Silva AC; Alves LI; Damasceno JG; Kulikowski L; Cunha-Neto E; da Silva MER
J Immunol Res; 2022; 2022():2734490. PubMed ID: 35903753
[TBL] [Abstract][Full Text] [Related]
20. Proteomics for the Discovery of Clinical Delirium Biomarkers: A Systematic Review of Major Studies.
Wiredu K; Aduse-Poku E; Shaefi S; Gerber SA
Anesth Analg; 2023 Mar; 136(3):422-432. PubMed ID: 36580411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
